As of the latest Form 4 filed Jun 17, 2026.
What Arcutis Biotherapeutics Inc insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 50 most recent filings for ARQT.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-17 | 2026-06-17 | Welgus Howard G. Director | SSale | −635.00 | $25.67 | $16.3K | Yes (planned) | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | LIN SUE-JEAN Director | SSale | −4.95K | $24.38 | $121K | Yes (planned) | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Welgus Howard G. Director | SSale | −4.10K | $24.41 | $100.0K | Yes (planned) | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Welgus Howard G., Director | MExercise | +2.25K | $8.63 | $19.5K | Yes (planned) | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Welgus Howard G., Director | MExercise | +1.02K | $7.51 | $7.65K | Yes (planned) | Form 4 ↗ |
| 2026-06-17 | 2026-06-15 | Welgus Howard G., Director | MExercise | +822.00 | $6.52 | $5.36K | Yes (planned) | Form 4 ↗ |
| 2026-06-09 | 2026-06-05 | Heron Patrick J Director | AAward | +5.78K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-05 | LIN SUE-JEAN Director | AAward | +5.78K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-05 | Welgus Howard G. Director | AAward | +5.78K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-05 | Leonard Keith R Director | AAward | +5.78K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-05 | Curran Terrie Director | AAward | +5.78K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-05 | Munshi Amit Director | AAward | +5.78K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-05 | Gilbert Halley E Director | AAward | +5.78K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-06-09 | 2026-06-05 | Krishnamohan Neha Director | AAward | +5.78K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-05-13 | 2026-05-11 | Vairavan Latha SVP Chief Financial Officer | SSale | −435.00 | $21.05 | $9.16K | Yes (planned) | Form 4 ↗ |
| 2026-05-13 | 2026-05-11 | Burnett Patrick See Remarks | SSale | −222.00 | $21.05 | $4.67K | Yes (planned) | Form 4 ↗ |
| 2026-05-06 | 2026-05-04 | Vairavan Latha SVP Chief Financial Officer | SSale | −1.34K | $23.61 | $31.7K | Yes (planned) | Form 4 ↗ |
| 2026-05-06 | 2026-05-04 | Watanabe Todd See Remarks | SSale | −3.17K | $23.61 | $74.9K | Yes (planned) | Form 4 ↗ |
| 2026-05-06 | 2026-05-04 | Matsuda Masaru See Remarks | SSale | −884.00 | $23.61 | $20.9K | Yes (planned) | Form 4 ↗ |
| 2026-05-06 | 2026-05-04 | Matsuda Masaru, See Remarks | SSale | −7.37K | $23.27 | $172K | Yes (planned) | Form 4 ↗ |
| 2026-05-06 | 2026-05-04 | Burnett Patrick See Remarks | SSale | −684.00 | $23.61 | $16.1K | Yes (planned) | Form 4 ↗ |
| 2026-05-05 | 2026-05-01 | Welgus Howard G. Director | SSale | −7.14K | $22.99 | $164K | Yes (planned) | Form 4 ↗ |
| 2026-04-03 | 2026-04-01 | Welgus Howard G. Director | SSale | −10.0K | $23.88 | $239K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Leonard Keith R Director | SSale | −39.3K | $25.39 | $997K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Leonard Keith R, Director | MExercise | +12.2K | $7.51 | $91.8K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Leonard Keith R, Director | MExercise | +27.1K | $8.63 | $233K | Yes (planned) | Form 4 ↗ |
| 2026-03-04 | 2026-03-02 | Welgus Howard G. Director | SSale | −10.0K | $25.65 | $257K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Edwards Larry Todd See Remarks | SSale | −103.00 | $25.91 | $2.67K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Edwards Larry Todd, See Remarks | SSale | −3.58K | $25.16 | $90.2K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Watanabe Todd See Remarks | SSale | −1.07K | $25.91 | $27.7K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Watanabe Todd, See Remarks | SSale | −36.3K | $25.16 | $913K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Matsuda Masaru See Remarks | SSale | −1.99K | $25.70 | $51.1K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Matsuda Masaru, See Remarks | SSale | −193.00 | $25.91 | $5.00K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Matsuda Masaru, See Remarks | SSale | −6.55K | $25.16 | $165K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Vairavan Latha SVP Chief Financial Officer | SSale | −81.00 | $25.91 | $2.10K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Vairavan Latha, SVP Chief Financial Officer | SSale | −2.77K | $25.16 | $69.7K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Burnett Patrick See Remarks | SSale | −181.00 | $25.91 | $4.69K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-03-02 | Burnett Patrick, See Remarks | SSale | −6.11K | $25.16 | $154K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-02-27 | Edwards Larry Todd See Remarks | AAward | +30.0K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-02-27 | Watanabe Todd See Remarks | AAward | +102K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-02-27 | Matsuda Masaru See Remarks | SSale | −3.33K | $27.95 | $92.9K | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-02-27 | Matsuda Masaru, See Remarks | AAward | +37.0K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-02-27 | Vairavan Latha SVP Chief Financial Officer | AAward | +27.0K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2026-02-27 | Burnett Patrick See Remarks | AAward | +30.0K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2026-03-03 | 2022-08-18 | Burnett Patrick, See Remarks | AAward | +16.8K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
| 2024-05-03 | 2024-05-02 | Moore Matthew Richard SVP and Chief Business Officer | SSale | −4.68K | $8.74 | $40.9K | Yes (planned) | Form 4 ↗ |
| 2024-05-03 | 2024-05-02 | Watanabe Todd Franklin See Remarks | SSale | −13.8K | $8.74 | $120K | Yes (planned) | Form 4 ↗ |
| 2024-05-03 | 2024-05-02 | Matsuda Masaru See Remark | SSale | −5.02K | $8.74 | $43.8K | Yes (planned) | Form 4 ↗ |
| 2024-05-03 | 2024-05-02 | Burnett Patrick See Remarks | SSale | −9.55K | $8.74 | $83.5K | Yes (planned) | Form 4 ↗ |
| 2024-05-03 | 2024-05-01 | Moore Matthew Richard SVP and Chief Business Officer | AAward | +4.17K | $0.00 | $0.00 | Yes (planned) | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also ARQT’s full analysis or the market-wide insider trading feed. The tabs above jump to ARQT’s other SEC data.
Source: SEC Form 4 filings for ARQT, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.